Compared with the healthy control group, the myeloperoxidase/PON1 ratio of RA patients with a history of CVD was higher, indicating that HDL dysfunction determined by myeloperoxidase/PON1 ratio may be related to the increase of CVD in RA (109). Here, PON1 is linked to rheumatoid arthritis.